Atara Biotherapeutics Inc... (ATRA)
NASDAQ: ATRA
· Real-Time Price · USD
12.24
0.52 (4.44%)
At close: Aug 15, 2025, 2:37 PM
4.44% (1D)
| Bid | 12.1 |
| Market Cap | 85.96M |
| Revenue (ttm) | 199.73M |
| Net Income (ttm) | -15.64M |
| EPS (ttm) | 0.72 |
| PE Ratio (ttm) | 17 |
| Forward PE | -23.82 |
| Analyst | Buy |
| Ask | 12.29 |
| Volume | 87,429 |
| Avg. Volume (20D) | 56,262 |
| Open | 11.72 |
| Previous Close | 11.72 |
| Day's Range | 11.52 - 12.49 |
| 52-Week Range | 5.00 - 18.70 |
| Beta | 0.26 |
About ATRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Atara Biotherapeutics has released their quartely earnings
on Aug 11, 2025:
Next Earnings Release
Atara Biotherapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 days ago
+11.82%
Atara Biotherapeutics shares are trading higher af...
Unlock content with
Pro Subscription
3 months ago
+15.13%
Atara Biotherapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.
